Primary Record
AT9283
- In stock
- 7,382 g
- Purity
- 98.2 %
- CAS
- 896466-04-9
Compound Identifiers & Properties
- CAS
- 896466-04-9
- PubChem CID
- 135398495
- SMILES
- C1CC1NC(=O)NC2=C(NN=C2)C3=NC4=C(N3)C=C(C=C4)CN5CCOCC5
- Canonical SMILES
- O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1
Names & Synonyms
- AT9283
- 896466-04-9
- AT-9283
- 1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
- XAV9KYN9WL
- AT-9283 free base
- UNII-XAV9KYN9WL
- AT 9283
- AT-9283 L-lactate
- RefChem:560290
- cc-56
- D05PZB
- MFCD12031513
- MLS006011044
- SCHEMBL545809
- SCHEMBL545942
- AT 9283 [WHO-DD]
- Multikinase Inhibitor AT9283
- C19H23N7O2
- CHEMBL495727
- GTPL7949
- orb1304573
- SCHEMBL15005492
- SCHEMBL15005494
- SCHEMBL24336623
- SCHEMBL29353018
- Aurora kinase inhibitor AT9283
- BDBM27087
- CTK8C2842
- KS-00001DTX
- 896466-04-9 (free base)
- EX-A201
- SYN1011
- CHEBI:125514
- LOLPPWBBNUVNQZ-UHFFFAOYSA-N
- VRXXZJLHPWWXIX-ISLYRVAYSA-N
- BCPP000379
- DTXSID401026047
- GLXC-06792
- HMS3244O09
- HMS3244O10
- HMS3244P09
- HMS3654G08
- HMS3673I15
- BCP11714
- ANW-69120
- BDBM50243388
- EBC-79023
- NSC760144
- NSC799339
- RS0013
- s1134
- ZINC34637502
- ZINC38995988
- AKOS016006006
- AKOS026750645
- ZINC136047369
- AT9 283
- AT9283?
- BCP9000337
- CCG-268424
- CS-0107
- NSC-760144
- NSC-799339
- QC-4297
- SDCCGSBI-0654347.P001
- CID11496629
- CID11696609
- NCGC00346493-01
- NCGC00346493-06
- NCGC00346493-09
- NCGC00389697-02
- NCGC00389697-03
- pyrazole-benzimidazole urea analogue, 16
- AC-32808
- AJ-97300
- AK-43760
- AS-16186
- BC659956
- CID 11496629
- HY-50514
- SMR004702836
- CID:135398495
- SID:386048295
- AB0033752
- AT 9283, (2S)-2-hydroxy-propanoic acid salt
- DB-078462
- A4117
- NS00072317
- SW220119-1
- X7478
- J2.685.245E
- A10095
- F17373
- W-5568
- 896466-76-5
- 466C049
- A861105
- A861107
- A900407
- AT 9283; AT-9283; AT-9283 free base
- C535237
- EN300-20637992
- BRD-K24576554-001-01-4
- BRD-K24576554-001-04-8
- Q27074571
- Q27216136
- Q27453557
- Urea, N-cyclopropyl-N'-(3-(6-(4-morpholinylmethyl)-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl)-
- 1-cyclopropyl-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea
- 1-Cyclopropyl-3-{3-[5-(Morpholin-4-Ylmethyl)-1h-Benzimidazol-2-Yl]-1h-Pyrazol-4-Yl}urea
- 3-cyclopropyl-1-{3-[5-(morpholin-4-ylmethyl)-1H-1,3-benzodiazol-2-yl]-1H-pyrazol-4-yl}urea
- B0084-100114
- AT-9283, AT 9283, 896466-04-9
- 1-cyclopropyl-3-[(3E)-3-[5-(morpholin-4-ylmethyl)benzimidazol-2-ylidene]-1,2-dihydropyrazol-4-yl]urea
- 1-cyclopropyl-3-[(3Z)-3-[5-(morpholin-4-ylmethyl)benzimidazol-2-ylidene]-1,2-dihydropyrazol-4-yl]urea
- 1-cyclopropyl-3-(3-(5-(morpholinomethyl)-1h-benzo[d]imidazol-2-yl)-1h-pyrazol-4-yl) urea
- 1-cyclopropyl-3-(3-(5-morpholin-4-ylmethyl-1h-benzoimidazol-2-yl)-1h-pyrazol-4-yl)urea
- 1-cyclopropyl-3-(3-(6-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
- 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1h-benzoimidazol-2-yl )-1h-pyrazol-4-yl]-urea
- 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea
- 1-Cyclopropyl-3-[3-[5-(morpholinomethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea
- 1-cyclopropyl-3-[5-[6-(morpholinomethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea
- N-cyclopropyl-N'-[3-[5-(4-morpholinylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]Urea
- 1-cyclopropyl-3-((3Z)-3-(5-(morpholin-4-ylmethyl)benzimidazol-2-ylidene)-1,2-dihydropyrazol-4-yl)urea
- 1-cyclopropyl-3-[3-[5-(4-morpholinylmethyl)-2-benzimidazolylidene]-1,2-dihydropyrazol-4-yl]urea
- 1133385-83-7
- 3-cyclopropyl-1-(3-{5-[(morpholin-4-yl)methyl]-1H-1,3-benzodiazol-2-yl}-1H-pyrazol-4-yl)urea
- 3-cyclopropyl-1-(3-{6-[(morpholin-4-yl)methyl]-1H-1,3-benzodiazol-2-yl}-1H-pyrazol-4-yl)urea
- 3-cyclopropyl-1-{3-[(2Z)-5-(morpholin-4-ylmethyl)-1,3-benzodiazol-2-ylidene]-1,2-dihydropyrazol-4-yl}urea
- 35R
- 849094-18-4
- AT 9283; 1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea; N-Cyclopropyl-N'-[3-[5-(4-morpholinylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-urea